Closed MikeMcC399 closed 2 years ago
Thanks for your report @MikeMcC399. We have added this information to the same internal ticket that we used for the 16th recommendation. Internal Tracking ID: EXPOSUREAPP-11340
Corona-Warn-App Open Source Team
@larswmh
Thank you. Can you give some indication of the plans?
@MikeMcC399
We will ask internally about when implementation is planned.
@larswmh
We will ask internally about when implementation is planned.
What was the result of your internal question?
The current booster rules on https://distribution.dcc-rules.de/bnrules contain no rules for holders of a Certificate of Recovery.
The Epidemiologisches Bulletin 3 2022 contains recommendations in Table 5 on page 18 (Empfehlung zur Durchführung der Grundimmunisierung und Auffrischimpfung bei unterschiedlichen Impfanamnesen und nach durchgemachter SARS-CoV-2-Infektion bei Immungesunden (Stand: 20.01.2022)) which includes a recommendation for vaccination after 3 months following an infection.
It would be important to activate such a rule in CWA, also with regard to the shortening of validity of Certificate of Recovery from 180 days to 90 days by the German government regulations and RKI promulgations which took effect on Jan 15, 2022.
@All, we are working on a statement about the approach to planning and implementing features in the app. Please keep in mind that our objective is to stay as up-to-date as possible with the app. However, development (including testing) will always lag behind the current decision-making process. So, yes, we are aware that the released version may not always reflect national and/or regional rulings or dynamically changing decisions and recommendations of the authorities. However, we will use the momentum and we are on track to cover the ongoing legislative amendments with the next versions of the app.
Please remain patient.
The STIKO-Empfehlung zur COVID-19-Impfung has been updated:
"Am 15.2.2022 ist die 18. Aktualisierung der COVID-19-Impfempfehlung erschienen. Darin empfiehlt die STIKO nach abgeschlossener COVID-19-Grundimmunisierung und erfolgter 1. Auffrischimpfung eine 2. Auffrischimpfung mit einem mRNA-Impfstoff für besonders gesundheitlich gefährdete bzw. exponierte Personengruppen.
Alternativ zu den bereits empfohlenen COVID-19-Impfstoffen empfiehlt die STIKO zur Grundimmunisierung gegen COVID-19 den Impfstoff Nuvaxovid von Novavax für Personen ≥18 Jahre mit 2 Impfstoffdosen im Abstand von mindestens 3 Wochen".
Closing this issue, which explicitly refers to the 17th recommendation, since it is now obsolete. The 18th recommendation is now current.
@GisoSchroederSAP
we are working on a statement about the approach to planning and implementing features in the app.
Technical details
Describe the bug
Booster rules used by the app do not reflect the 17th STIKO recommendations as published in Epidemiologisches Bulletin 3 2022.
Steps to reproduce the issue
Either scan available certificates into CWA and view the news output by the app or view the rules.
To view all rules run the following script in a Bash terminal:
Expected behavior
The rules used by CWA should correspond to the official recommendations published by the STIKO. See RKI's website.
Possible Fix
Review all rules provided on https://distribution.dcc-rules.de/bnrules for conformity with the official STIKO recommendations published in Epidemiologisches Bulletin 3 2022.
Additional context
Reference
STIKO-Empfehlung zur COVID-19-Impfung:
"Am 20.1.2022 ist die 17. Aktualisierung der COVID-19-Impfempfehlung erschienen. Darin empfiehlt die STIKO die Auffrischimpfung für 12- bis 17-jährige Kinder und Jugendliche mit dem mRNA-Impfstoff Comirnaty (30 μg), in einem Zeitfenster von 3 bis 6 Monaten nach der abgeschlossenen Grundimmunisierung. Die STIKO empfiehlt außerdem die Optimierung der Grundimmunisierung mit einem mRNA-Impfstoff nach vorausgegangener Impfung mit der COVID-19 Vaccine Janssen und auch hier eine 3. Impfstoffdosis (Auffrischimpfung) im Abstand von mindestens 3 Monaten zur 2. Impfstoffdosis mit einem mRNA-Impfstoff."
The Epidemiologisches Bulletin 3 2022 published on Jan 20, 2022.
Internal Tracking ID: EXPOSUREAPP-11340